Abstract
The efficacy of Helicobacter pylori eradication therapy for the prevention of preneoplastic lesions in gastric cancer remains controversial. A new placebo-controlled trial and a large-scale observational study tackle this problem and show the positive effects of eradication therapy.
Original language | English |
---|---|
Pages (from-to) | 458-460 |
Number of pages | 3 |
Journal | Nature Reviews Gastroenterology and Hepatology |
Volume | 15 |
Issue number | 8 |
DOIs | |
Publication status | Published - 2018 Aug 1 |
ASJC Scopus subject areas
- Hepatology
- Gastroenterology